Mannkind Corp (MNKD) 6.54 $MNKD
MNKD July 19th Options Begin Trading
at The Street - Tue Apr 08, 10:17AM CDT
Investors in MannKind Corp saw new options become available today, for the July 19th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 102 days until expiration the newly...
Company News for April 08, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 9:06AM CDT
Companies in the News are: QCOR,MNK,GAS,MNKD,PBR
Will This Coverage Initiation Help MannKind (MNKD) Stock Today?
at The Street - Tue Apr 08, 8:20AM CDT
MannKind (MNKD) had coverage initiated on its shares with a 'market perform' rating by Brinson Patrick
MannKind Slips on Afrezza Approval Delay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 7:52AM CDT
The PDUFA date for MannKind's Afrezza was pushed back by the FDA by three months to Jul 15.
'Fast Money' Recap: The Profit-Taking Spreads
at The Street - Tue Apr 08, 4:00AM CDT
The trading panel discussed how investors are selling all sorts of sectors, including steel and home improvement.
Petr Announces Well Online and Estimates 26,000 Barrels of Oil per Day; MannKind's Afressa Drug Decision Extended by the FDA
ACCESSWIRE - Tue Apr 08, 12:05AM CDT
Petr (NYSE: PBR) - For an in-depth report on Petr follow: www.BullTrends.com/stockquote/PBR
MannKind vs. Idenix: Better Biotech Buy
David Williamson, The Motley Fool - Motley Fool - Mon Apr 07, 6:17PM CDT
In this video after a big day in the biotech sector, Motley Fool health-care analyst David Williamson takes investors through today's big winner and loser. Idenix is the winner for the day, up 10% after posting solid results in a...
Alcoa and Pfizer are big market movers
AP - Mon Apr 07, 3:38PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
3 Huge Stocks on Traders' Radars
at The Street - Mon Apr 07, 1:11PM CDT
Here's how to trade some of the most active stocks on the market today.
Nasdaq stocks posting largest percentage decreases
AP - Mon Apr 07, 12:50PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Why MannKind Corp. Shares Made One Giant Leap Downward
Sean Williams, The Motley Fool - Motley Fool - Mon Apr 07, 12:09PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of MannKind , a clinical-stage...
Jim Cramer on MannKind (MNKD), Visa (V), FireEye (FEYE), Linn Energy (LINE)
at The Street - Mon Apr 07, 10:45AM CDT
MannKind (MNKD) has doubled in value after a Food and Drug Administration panel recommended approval of its insulin drug Afrezza. The subsequent media coverage was extremely positive, but the stock dropped a bit after the FDA delayed its decision....
Today’s Top Biotech Stories: MannKind, Mallinckrodt, Questcor, and Novartis
Leo Sun, The Motley Fool - Motley Fool - Mon Apr 07, 8:18AM CDT
Let's take a quick look at four stocks which could make waves in the biotech sector this morning: MannKind , Mallinckrodt , Questcor , and Novartis . MannKind plunges after a three month extension of its PDUFA date MannKind has fallen...
Drug Recommendations, Legal Updates, Awards, Stock Price Movements, and Upcoming Results and Conference Call Schedules - Analyst Notes on MannKind, Mylan, WellPoint, Valeant, and Forest Laboratories
PR Newswire - Mon Apr 07, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding MannKind Corporation (NASDAQ: MNKD), Mylan Inc. (NASDAQ: MYL), WellPoint Inc. (NYSE: WLP), Valeant Pharmaceuticals International Inc. (NYSE: VRX), and Forest Laboratories Inc. (NYSE: FRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
MannKind Updates Status of New Drug Application for AFREZZA(R)
GlobeNewswire - Mon Apr 07, 3:00AM CDT
MannKind Corporation (Nasdaq:MNKD) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for AFREZZA by three months to July 15, 2014 in order to provide time for a full review of information submitted by MannKind in response to the FDA's requests.
5 of Last Week's Biggest Winners
Rick Munarriz, The Motley Fool - Motley Fool - Sun Apr 06, 7:30AM CDT
It was a rocky week on Wall Street, with Nasdaq stocks inching lower and the Dow inching higher, but there were plenty of stocks really making some serious moves. Let's take a closer look at five of this past week's biggest scorchers. ...
This Week in Biotech: Data Disappointments Come in Threes
Sean Williams, The Motley Fool - Motley Fool - Sat Apr 05, 1:15PM CDT
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...
3 Humongous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Apr 05, 7:00AM CDT
Uncle Sam delivered really good news to several health-care stocks this week. As a result, shareholders of three of those stocks enjoyed strong double-digit gains in a matter of days. One of this week's winners benefited from a resounding...
This Week's 5 Smartest Stock Moves
Rick Munarriz, The Motley Fool - Motley Fool - Fri Apr 04, 4:15PM CDT
If you're feeling good about the market, you're not alone. Take my hand as we go over some of this week's more uplifting headlines. 1. Amazon opens Fire Amazon.com is finally rolling out the set-top media-player that it was rumored to be...
Most active Nasdaq-traded stocks
AP - Thu Apr 03, 5:24PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MNKD July 19th Options Begin Trading
at The Street - Tue Apr 08, 10:17AM CDT
Investors in MannKind Corp saw new options become available today, for the July 19th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 102 days until expiration the newly...
Company News for April 08, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 9:06AM CDT
Companies in the News are: QCOR,MNK,GAS,MNKD,PBR
Will This Coverage Initiation Help MannKind (MNKD) Stock Today?
at The Street - Tue Apr 08, 8:20AM CDT
MannKind (MNKD) had coverage initiated on its shares with a 'market perform' rating by Brinson Patrick
MannKind Slips on Afrezza Approval Delay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 7:52AM CDT
The PDUFA date for MannKind's Afrezza was pushed back by the FDA by three months to Jul 15.
'Fast Money' Recap: The Profit-Taking Spreads
at The Street - Tue Apr 08, 4:00AM CDT
The trading panel discussed how investors are selling all sorts of sectors, including steel and home improvement.
Petr Announces Well Online and Estimates 26,000 Barrels of Oil per Day; MannKind's Afressa Drug Decision Extended by the FDA
ACCESSWIRE - Tue Apr 08, 12:05AM CDT
Petr (NYSE: PBR) - For an in-depth report on Petr follow: www.BullTrends.com/stockquote/PBR
MannKind vs. Idenix: Better Biotech Buy
David Williamson, The Motley Fool - Motley Fool - Mon Apr 07, 6:17PM CDT
In this video after a big day in the biotech sector, Motley Fool health-care analyst David Williamson takes investors through today's big winner and loser. Idenix is the winner for the day, up 10% after posting solid results in a...
Alcoa and Pfizer are big market movers
AP - Mon Apr 07, 3:38PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
3 Huge Stocks on Traders' Radars
at The Street - Mon Apr 07, 1:11PM CDT
Here's how to trade some of the most active stocks on the market today.
Nasdaq stocks posting largest percentage decreases
AP - Mon Apr 07, 12:50PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Why MannKind Corp. Shares Made One Giant Leap Downward
Sean Williams, The Motley Fool - Motley Fool - Mon Apr 07, 12:09PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of MannKind , a clinical-stage...
Jim Cramer on MannKind (MNKD), Visa (V), FireEye (FEYE), Linn Energy (LINE)
at The Street - Mon Apr 07, 10:45AM CDT
MannKind (MNKD) has doubled in value after a Food and Drug Administration panel recommended approval of its insulin drug Afrezza. The subsequent media coverage was extremely positive, but the stock dropped a bit after the FDA delayed its decision....
Today’s Top Biotech Stories: MannKind, Mallinckrodt, Questcor, and Novartis
Leo Sun, The Motley Fool - Motley Fool - Mon Apr 07, 8:18AM CDT
Let's take a quick look at four stocks which could make waves in the biotech sector this morning: MannKind , Mallinckrodt , Questcor , and Novartis . MannKind plunges after a three month extension of its PDUFA date MannKind has fallen...
Drug Recommendations, Legal Updates, Awards, Stock Price Movements, and Upcoming Results and Conference Call Schedules - Analyst Notes on MannKind, Mylan, WellPoint, Valeant, and Forest Laboratories
PR Newswire - Mon Apr 07, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding MannKind Corporation (NASDAQ: MNKD), Mylan Inc. (NASDAQ: MYL), WellPoint Inc. (NYSE: WLP), Valeant Pharmaceuticals International Inc. (NYSE: VRX), and Forest Laboratories Inc. (NYSE: FRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
MannKind Updates Status of New Drug Application for AFREZZA(R)
GlobeNewswire - Mon Apr 07, 3:00AM CDT
MannKind Corporation (Nasdaq:MNKD) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for AFREZZA by three months to July 15, 2014 in order to provide time for a full review of information submitted by MannKind in response to the FDA's requests.
5 of Last Week's Biggest Winners
Rick Munarriz, The Motley Fool - Motley Fool - Sun Apr 06, 7:30AM CDT
It was a rocky week on Wall Street, with Nasdaq stocks inching lower and the Dow inching higher, but there were plenty of stocks really making some serious moves. Let's take a closer look at five of this past week's biggest scorchers. ...
This Week in Biotech: Data Disappointments Come in Threes
Sean Williams, The Motley Fool - Motley Fool - Sat Apr 05, 1:15PM CDT
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and...
3 Humongous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Apr 05, 7:00AM CDT
Uncle Sam delivered really good news to several health-care stocks this week. As a result, shareholders of three of those stocks enjoyed strong double-digit gains in a matter of days. One of this week's winners benefited from a resounding...
This Week's 5 Smartest Stock Moves
Rick Munarriz, The Motley Fool - Motley Fool - Fri Apr 04, 4:15PM CDT
If you're feeling good about the market, you're not alone. Take my hand as we go over some of this week's more uplifting headlines. 1. Amazon opens Fire Amazon.com is finally rolling out the set-top media-player that it was rumored to be...
Most active Nasdaq-traded stocks
AP - Thu Apr 03, 5:24PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
